{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T18:49:24Z","timestamp":1793731764609,"version":"4.6.1"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T00:00:00Z","timestamp":1762387200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T00:00:00Z","timestamp":1762387200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-22674-z","type":"journal-article","created":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T13:29:37Z","timestamp":1762435777000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Proinflammatory macrophage secretome enhances temozolomide sensitivity in glioblastoma via pSTAT3-mediated downregulation of DNA repair enzymes"],"prefix":"10.1038","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9140-5123","authenticated-orcid":false,"given":"Susana","family":"L\u00f3pez-L\u00f3pez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6441-7735","authenticated-orcid":false,"given":"Beatriz","family":"Castro-Robles","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-1160-2330","authenticated-orcid":false,"given":"Natalia","family":"Garc\u00eda-Flores","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3843-3912","authenticated-orcid":false,"given":"Mar\u00eda Jos\u00e9 M.","family":"D\u00edaz-Guerra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-3331-3069","authenticated-orcid":false,"given":"Lourdes","family":"Arias-Salazar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4337-0530","authenticated-orcid":false,"given":"Hern\u00e1n","family":"Sandoval","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0298-5283","authenticated-orcid":false,"given":"Daniel","family":"Garc\u00eda-P\u00e9rez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2211-6851","authenticated-orcid":false,"given":"Christoph J.","family":"Klein-Zampa\u00f1a","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7757-9709","authenticated-orcid":false,"given":"Rosa A.","family":"Barbella-Aponte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3625-0987","authenticated-orcid":false,"given":"Tom\u00e1s","family":"Segura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9368-4832","authenticated-orcid":false,"given":"Gemma","family":"Serrano-Heras","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,11,6]]},"reference":[{"key":"22674_CR1","doi-asserted-by":"publisher","first-page":"2412","DOI":"10.3390\/cancers14102412","volume":"14","author":"S Grochans","year":"2022","unstructured":"Grochans, S. et al. Epidemiology of glioblastoma multiforme\u2013Literature review. Cancers (Basel) 14, 2412. https:\/\/doi.org\/10.3390\/cancers14102412 (2022).","journal-title":"Cancers (Basel)"},{"key":"22674_CR2","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1056\/NEJMoa043330","volume":"352","author":"R Stupp","year":"2005","unstructured":"Stupp, R. et al. Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N. Engl. J. Med. 352, 987\u2013996. https:\/\/doi.org\/10.1056\/NEJMoa043330 (2005).","journal-title":"N. Engl. J. Med."},{"key":"22674_CR3","doi-asserted-by":"publisher","first-page":"1319","DOI":"10.3390\/cancers14051319","volume":"14","author":"JK Andersen","year":"2022","unstructured":"Andersen, J. K., Miletic, H. & Hossain, J. A. Tumor-associated macrophages in Gliomas\u2014Basic insights and treatment opportunities. Cancers (Basel) 14, 1319. https:\/\/doi.org\/10.3390\/cancers14051319 (2022).","journal-title":"Cancers (Basel)"},{"key":"22674_CR4","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1084\/jem.20150295","volume":"212","author":"A Mantovani","year":"2015","unstructured":"Mantovani, A. & Allavena, P. The interaction of anticancer therapies with tumor-associated macrophages. J. Exp. Med. 212, 435\u2013445. https:\/\/doi.org\/10.1084\/jem.20150295 (2015).","journal-title":"J. Exp. Med."},{"key":"22674_CR5","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1016\/j.biopha.2018.05.079","volume":"104","author":"Y Zhang","year":"2018","unstructured":"Zhang, Y. et al. Overexpression of STAT1 suppresses angiogenesis under hypoxia by regulating VEGF\u2013A in human glioma cells. Biomed. Pharmacother. 104, 566\u2013575. https:\/\/doi.org\/10.1016\/j.biopha.2018.05.079 (2018).","journal-title":"Biomed. Pharmacother"},{"key":"22674_CR6","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1016\/j.cellsig.2006.09.003","volume":"19","author":"HS Kim","year":"2007","unstructured":"Kim, H. S. & Lee, M. S. STAT1 as a key modulator of cell death. Cell. Signal. 19, 454\u2013465. https:\/\/doi.org\/10.1016\/j.cellsig.2006.09.003 (2007).","journal-title":"Cell. Signal."},{"key":"22674_CR7","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1016\/j.bbrc.2013.04.087","volume":"435","author":"Z Han","year":"2013","unstructured":"Han, Z. et al. Silencing of the STAT3 signaling pathway reverses the inherent and induced chemoresistance of human ovarian cancer cells. Biochem. Biophys. Res. Commun. 435, 188\u2013194. https:\/\/doi.org\/10.1016\/j.bbrc.2013.04.087 (2013).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"22674_CR8","doi-asserted-by":"publisher","first-page":"660","DOI":"10.1038\/cdd.2016.162","volume":"24","author":"Y Jiang","year":"2017","unstructured":"Jiang, Y. et al. STAT1 mediates transmembrane TNF-alpha-induced formation of death-inducing signaling complex and apoptotic signaling via TNFR1. Cell. Death Differ. 24, 660\u2013671. https:\/\/doi.org\/10.1038\/cdd.2016.162 (2017).","journal-title":"Cell. Death Differ."},{"key":"22674_CR9","doi-asserted-by":"publisher","unstructured":"Ge, Y. et al. Interactions between tumor-associated macrophages and regulated cell death: Therapeutic implications in immuno-oncology. Front. Oncol. 14, 1449696. https:\/\/doi.org\/10.3389\/fonc.2024.1449696 (2024).","DOI":"10.3389\/fonc.2024.1449696"},{"key":"22674_CR10","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1002\/jcp.25896","volume":"233","author":"M Binabaj","year":"2018","unstructured":"Binabaj, M. et al. The prognostic value of MGMT promoter methylation in glioblastoma: A meta-analysis of clinical trials. J. Cell. Physiol. 233, 378\u2013386. https:\/\/doi.org\/10.1002\/jcp.25896 (2018).","journal-title":"J. Cell. Physiol."},{"key":"22674_CR11","doi-asserted-by":"publisher","first-page":"22185","DOI":"10.1038\/s41598-020-78868-0","volume":"10","author":"G Serrano-Heras","year":"2020","unstructured":"Serrano-Heras, G. et al. Involvement of N-methylpurine DNA glycosylase in resistance to temozolomide in patient-derived glioma cells. Sci. Rep. 10, 22185. https:\/\/doi.org\/10.1038\/s41598-020-78868-0 (2020).","journal-title":"Sci. Rep."},{"key":"22674_CR12","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1172\/JCI59334","volume":"122","author":"S Agnihotri","year":"2012","unstructured":"Agnihotri, S. et al. Alkylpurine\u2013DNA\u2013N-glycosylase confers resistance to temozolomide in xenograft models of glioblastoma multiforme and is associated with poor survival in patients. J. Clin. Invest. 122, 253\u2013266. https:\/\/doi.org\/10.1172\/JCI59334 (2012).","journal-title":"J. Clin. Invest."},{"key":"22674_CR13","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1007\/s10238-012-0201-x","volume":"13","author":"AP Montaldi","year":"2013","unstructured":"Montaldi, A. P. & Sakamoto-Hojo, E. T. Methoxyamine sensitizes the resistant glioblastoma T98G cell line to the alkylating agent temozolomide. Clin. Exp. Med. 13, 279\u2013288. https:\/\/doi.org\/10.1007\/s10238-012-0201-x (2013).","journal-title":"Clin. Exp. Med."},{"key":"22674_CR14","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1186\/1748-717X-8-65","volume":"8","author":"L Barazzuol","year":"2013","unstructured":"Barazzuol, L. et al. Evaluation of poly (ADP-ribose) polymerase inhibitor ABT-888 combined with radiotherapy and temozolomide in glioblastoma. Radiat. Oncol. 8, 65. https:\/\/doi.org\/10.1186\/1748-717X-8-65 (2013).","journal-title":"Radiat. Oncol."},{"key":"22674_CR15","doi-asserted-by":"publisher","first-page":"3572","DOI":"10.3390\/cancers14153572","volume":"14","author":"J Li","year":"2022","unstructured":"Li, J. et al. Overcoming temozolomide resistance in glioblastoma via enhanced NAD\u2009+\u2009Bioavailability and Inhibition of Poly-ADP-Ribose glycohydrolase. Cancers (Basel) 14, 3572. https:\/\/doi.org\/10.3390\/cancers14153572 (2022).","journal-title":"Cancers (Basel)"},{"key":"22674_CR16","doi-asserted-by":"publisher","first-page":"1289","DOI":"10.1158\/1535-7163.MCT-11-0801","volume":"11","author":"S Kohsaka","year":"2012","unstructured":"Kohsaka, S. et al. STAT3 Inhibition overcomes temozolomide resistance in glioblastoma by downregulating MGMT expression. Mol. Cancer Ther. 11, 1289\u20131299. https:\/\/doi.org\/10.1158\/1535-7163.MCT-11-0801 (2012).","journal-title":"Mol. Cancer Ther."},{"key":"22674_CR17","doi-asserted-by":"publisher","first-page":"1337","DOI":"10.1245\/s10434-013-3380-0","volume":"21","author":"X Wang","year":"2014","unstructured":"Wang, X. et al. Gain of function of mutant TP53 in glioblastoma: Prognosis and response to Temozolomide. Ann. Surg. Oncol. 21, 1337\u20131344. https:\/\/doi.org\/10.1245\/s10434-013-3380-0 (2014).","journal-title":"Ann. Surg. Oncol."},{"key":"22674_CR18","doi-asserted-by":"publisher","first-page":"1235","DOI":"10.1016\/j.chembiol.2006.09.01","volume":"13","author":"J Schust","year":"2006","unstructured":"Schust, J., Sperl, B., Hollis, A., Mayer, T. U. & Berg, T. Stattic: A small-molecule inhibitor of STAT3 activation and dimerization. Chem. Biol. 13, 1235\u20131242. https:\/\/doi.org\/10.1016\/j.chembiol.2006.09.01 (2006).","journal-title":"Chem. Biol."},{"key":"22674_CR19","doi-asserted-by":"publisher","first-page":"113372","DOI":"10.1016\/j.intimp.2024.113372","volume":"143","author":"Y Wang","year":"2024","unstructured":"Wang, Y. et al. The IL-1\u03b2\/STAT1 axis inhibits STAT3 function via sequestration of the transcriptional activator GLIS2, leading to postoperative vascular dysfunction. Int. Immunopharmacol. 143, 113372. https:\/\/doi.org\/10.1016\/j.intimp.2024.113372 (2024).","journal-title":"Int. Immunopharmacol."},{"key":"22674_CR20","doi-asserted-by":"publisher","first-page":"2658","DOI":"10.1038\/s41388-018-0613-5","volume":"38","author":"B Flood","year":"2019","unstructured":"Flood, B. et al. Caspase-11 regulates the tumour suppressor function of STAT1 in a murine model of colitis-associated carcinogenesis. Oncogene 38, 2658\u20132674. https:\/\/doi.org\/10.1038\/s41388-018-0613-5 (2019).","journal-title":"Oncogene"},{"key":"22674_CR21","doi-asserted-by":"publisher","first-page":"583","DOI":"10.3892\/ol.2011.300","volume":"2","author":"M Liu","year":"2011","unstructured":"Liu, M., Guo, S. & Stiles, J. K. The emerging role of CXCL10 in cancer (Review). Oncol. Lett. 2, 583\u2013589. https:\/\/doi.org\/10.3892\/ol.2011.300 (2011).","journal-title":"Oncol. Lett."},{"key":"22674_CR22","doi-asserted-by":"publisher","unstructured":"Chan, T. Y. H., Wong, J. S. Y., Kiang, K. M. Y., Sun, C. W. Y. & Leung, G. K.-K. The duality of CXCR3 in glioblastoma: Unveiling autocrine and paracrine mechanisms for novel therapeutic approaches. Cell. Death Dis. 14, 835. https:\/\/doi.org\/10.1038\/s41419-023-06354-2 (2023).","DOI":"10.1038\/s41419-023-06354-2"},{"key":"22674_CR23","doi-asserted-by":"publisher","first-page":"1347","DOI":"10.3390\/cells9061347","volume":"9","author":"M Kang","year":"2020","unstructured":"Kang, M. et al. Multiple functions of Fubp1 in cell cycle progression and cell survival. Cells 9, 1347. https:\/\/doi.org\/10.3390\/cells9061347 (2020).","journal-title":"Cells"},{"key":"22674_CR24","doi-asserted-by":"publisher","first-page":"1561560","DOI":"10.3389\/fimmu.2025.1561560","volume":"16","author":"B Huang","year":"2025","unstructured":"Huang, B., Yuan, Q., Sun, J., Wang, C. & Yang, D. Thymidine phosphorylase in nucleotide metabolism: Physiological functions and its implications in tumorigenesis and anti-cancer therapy. Front. Immunol. 16, 1561560. https:\/\/doi.org\/10.3389\/fimmu.2025.1561560 (2025).","journal-title":"Front. Immunol."},{"key":"22674_CR25","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1007\/s10555-006-9001-7","volume":"25","author":"A Mantovani","year":"2006","unstructured":"Mantovani, A., Schioppa, T., Porta, C., Allavena, P. & Sica, A. Role of tumor-associated macrophages in tumor progression and invasion. Cancer Metastasis Rev. 25, 315\u2013322. https:\/\/doi.org\/10.1007\/s10555-006-9001-7 (2006).","journal-title":"Cancer Metastasis Rev."},{"key":"22674_CR26","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1093\/neuonc\/noz212","volume":"22","author":"J Wei","year":"2020","unstructured":"Wei, J. et al. Immune biology of glioma-associated macrophages and microglia: Functional and therapeutic implications. Neuro Oncol. 22, 180\u2013194. https:\/\/doi.org\/10.1093\/neuonc\/noz212 (2020).","journal-title":"Neuro Oncol."},{"key":"22674_CR27","doi-asserted-by":"publisher","first-page":"17","DOI":"10.20517\/cdr.2020.79","volume":"4","author":"N Singh","year":"2021","unstructured":"Singh, N., Miner, A., Hennis, L. & Mittal, S. Mechanisms of Temozolomide resistance in glioblastoma\u2014a comprehensive review. Cancer Drug Resist. 4, 17\u201343. https:\/\/doi.org\/10.20517\/cdr.2020.79 (2021).","journal-title":"Cancer Drug Resist."},{"key":"22674_CR28","doi-asserted-by":"publisher","first-page":"e36839","DOI":"10.1016\/j.heliyon.2024.e36839","volume":"10","author":"Y Shao","year":"2024","unstructured":"Shao, Y., Han, S., Hou, Z., Yang, C. & Zhao, Y. Tumor-associated macrophages within the immunological milieu: An emerging focal point for therapeutic intervention. Heliyon 10, e36839. https:\/\/doi.org\/10.1016\/j.heliyon.2024.e36839 (2024).","journal-title":"Heliyon"},{"key":"22674_CR29","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1016\/j.biopha.2018.06.126","volume":"106","author":"W Song","year":"2018","unstructured":"Song, W., Thakor, P., Vesey, D. A., Gobe, G. C. & Morais, C. Conditioned medium from stimulated macrophages inhibits growth but induces an inflammatory phenotype in breast cancer cells. Biomed. Pharmacother. 106, 247\u2013254. https:\/\/doi.org\/10.1016\/j.biopha.2018.06.126 (2018).","journal-title":"Biomed. Pharmacother."},{"key":"22674_CR30","doi-asserted-by":"publisher","first-page":"101018","DOI":"10.1016\/j.tranon.2021.101018","volume":"14","author":"D Chai","year":"2021","unstructured":"Chai, D. et al. Absent in melanoma 2-mediating M1 macrophages facilitate tumor rejection in renal carcinoma. Transl Oncol. 14, 101018. https:\/\/doi.org\/10.1016\/j.tranon.2021.101018 (2021).","journal-title":"Transl Oncol."},{"key":"22674_CR31","doi-asserted-by":"publisher","first-page":"1354479","DOI":"10.3389\/fimmu.2024.1354479","volume":"15","author":"J Lentilhas-Gra\u00e7a","year":"2024","unstructured":"Lentilhas-Gra\u00e7a, J. et al. The secretome of macrophages has a differential impact on spinal cord injury recovery according to the polarization protocol. Front. Immunol. 15, 1354479. https:\/\/doi.org\/10.3389\/fimmu.2024.1354479 (2024).","journal-title":"Front. Immunol."},{"key":"22674_CR32","doi-asserted-by":"publisher","first-page":"4319","DOI":"10.1021\/acs.jproteome.5b00770","volume":"14","author":"Y Zhu","year":"2015","unstructured":"Zhu, Y. et al. A comprehensive proteomics analysis reveals a secretory path- and status-dependent signature of exosomes released from tumor-associated macrophages. J. Proteome Res. 14, 4319\u20134331. https:\/\/doi.org\/10.1021\/acs.jproteome.5b00770 (2015).","journal-title":"J. Proteome Res."},{"key":"22674_CR33","doi-asserted-by":"publisher","first-page":"890","DOI":"10.1093\/abbs\/gmv095","volume":"47","author":"L Zhao","year":"2015","unstructured":"Zhao, L. et al. Critical roles of chemokine receptor CCR5 in regulating glioblastoma proliferation and invasion. Acta Biochim. Biophys. Sin. (Shanghai) 47, 890\u2013898. https:\/\/doi.org\/10.1093\/abbs\/gmv095 (2015).","journal-title":"Acta Biochim. Biophys. Sin (Shanghai)"},{"key":"22674_CR34","doi-asserted-by":"publisher","first-page":"902","DOI":"10.1091\/mbc.e04-08-0687","volume":"16","author":"N Signoret","year":"2005","unstructured":"Signoret, N. et al. Agonist-induced endocytosis of CC chemokine receptor 5 is clathrin dependent. Mol. Biol. Cell. 16, 902\u2013917. https:\/\/doi.org\/10.1091\/mbc.e04-08-0687 (2005).","journal-title":"Mol. Biol. Cell."},{"key":"22674_CR35","doi-asserted-by":"publisher","first-page":"4189","DOI":"10.1200\/JCO.2007.11.5964","volume":"26","author":"ME Hegi","year":"2008","unstructured":"Hegi, M. E. et al. Correlation of O6-methylguanine methyltransferase (MGMT) promoter methylation with clinical outcomes in glioblastoma and clinical strategies to modulate MGMT activity. J. Clin. Oncol. 26, 4189\u20134199. https:\/\/doi.org\/10.1200\/JCO.2007.11.5964 (2008).","journal-title":"J. Clin. Oncol."},{"key":"22674_CR36","doi-asserted-by":"publisher","unstructured":"Liu, C. et al. Aberrant expression of N-methylpurine-DNA glycosylase influences patient survival in malignant gliomas. J. Biomed. Biotechnol. 760679. https:\/\/doi.org\/10.1155\/2012\/760679 (2012).","DOI":"10.1155\/2012\/760679"},{"key":"22674_CR37","doi-asserted-by":"publisher","first-page":"1198","DOI":"10.1158\/2159-8290.CD-14-0157","volume":"4","author":"S Agnihotri","year":"2014","unstructured":"Agnihotri, S. et al. ATM regulates 3-methylpurine-DNA glycosylase and promotes therapeutic resistance to alkylating agents. Cancer Discov. 4, 1198\u20131213. https:\/\/doi.org\/10.1158\/2159-8290.CD-14-0157 (2014).","journal-title":"Cancer Discov"},{"key":"22674_CR38","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1158\/1078-0432.CCR-06-1920","volume":"13","author":"ML Fishel","year":"2007","unstructured":"Fishel, M. L., He, Y., Smith, M. L. & Kelley, M. R. Manipulation of base excision repair to sensitize ovarian cancer cells to alkylating agent temozolomide. Clin. Cancer Res. 13, 260\u2013267. https:\/\/doi.org\/10.1158\/1078-0432.CCR-06-1920 (2007).","journal-title":"Clin. Cancer Res."},{"key":"22674_CR39","doi-asserted-by":"publisher","first-page":"e0178693","DOI":"10.1371\/journal.pone.0178693","volume":"12","author":"S Fosmark","year":"2017","unstructured":"Fosmark, S. et al. APNG as a prognostic marker in patients with glioblastoma. PLOS One 12, e0178693. https:\/\/doi.org\/10.1371\/journal.pone.0178693 (2017).","journal-title":"PLOS ONE"},{"key":"22674_CR40","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1093\/neuonc\/nor01","volume":"13","author":"J Tang","year":"2011","unstructured":"Tang, J. et al. N-methylpurine DNA glycosylase and DNA polymerase \u03b2 modulate BER inhibitor potentiation of glioma cells to Temozolomide. Neuro Oncol. 13, 471\u2013486. https:\/\/doi.org\/10.1093\/neuonc\/nor01 (2011).","journal-title":"Neuro Oncol."},{"key":"22674_CR41","doi-asserted-by":"publisher","unstructured":"Mathewson, N. D. et al. Inhibitory CD161 receptor identified in glioma-infiltrating T cells by single-cell analysis. Cell 184, 1281\u20131298.e26. https:\/\/doi.org\/10.1016\/j.cell.2021.01.022 (2021).","DOI":"10.1016\/j.cell.2021.01.022"},{"key":"22674_CR42","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.bbi.2015.07.019","volume":"53","author":"P Domingues","year":"2016","unstructured":"Domingues, P. et al. Tumor infiltrating immune cells in gliomas and meningiomas. Brain Behav. Immun. 53, 1\u201315. https:\/\/doi.org\/10.1016\/j.bbi.2015.07.019 (2016).","journal-title":"Brain Behav. Immun."},{"key":"22674_CR43","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1111\/j.1349-7006.2010.01772.x","volume":"102","author":"Y Fujiwara","year":"2011","unstructured":"Fujiwara, Y., Komohara, Y., Ikeda, T. & Takeya, M. Corosolic acid inhibits glioblastoma cell proliferation by suppressing the activation of signal transducer and activator of transcription-3 and nuclear factor\u2010kappa B in tumor cells and tumor\u2010associated macrophages. Cancer Sci. 102, 206\u2013211. https:\/\/doi.org\/10.1111\/j.1349-7006.2010.01772.x (2011).","journal-title":"Cancer Sci."},{"key":"22674_CR44","doi-asserted-by":"publisher","first-page":"828","DOI":"10.3389\/fimmu.2017.00828","volume":"8","author":"G Genard","year":"2017","unstructured":"Genard, G., Lucas, S. & Michiels, C. Reprogramming of tumor-associated macrophages with anticancer therapies: radiotherapy versus chemo- and immunotherapies. Front. Immunol. 8, 828. https:\/\/doi.org\/10.3389\/fimmu.2017.00828 (2017).","journal-title":"Front. Immunol."},{"key":"22674_CR45","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41420-022-00973-y","volume":"8","author":"T Yan","year":"2022","unstructured":"Yan, T. et al. Suppression of the hyaluronic acid pathway induces M1 macrophages polarization via STAT1 in glioblastoma. Cell. Death Discov. 8, 1\u201313. https:\/\/doi.org\/10.1038\/s41420-022-00973-y (2022).","journal-title":"Cell. Death Discov"},{"key":"22674_CR46","doi-asserted-by":"publisher","first-page":"1577","DOI":"10.1158\/1078-0432.CCR-05-2198","volume":"12","author":"M Ranson","year":"2006","unstructured":"Ranson, M. et al. Lomeguatrib, a potent inhibitor of O6-Alkylguanine-DNA-Alkyltransferase: Phase I Safety, Pharmacodynamic, and Pharmacokinetic trial and evaluation in combination with Temozolomide in patients with advanced solid tumors. Clin. L Cancer Res. 12, 1577\u20131584. https:\/\/doi.org\/10.1158\/1078-0432.CCR-05-2198 (2006).","journal-title":"Clin. L Cancer Res."},{"key":"22674_CR47","doi-asserted-by":"publisher","unstructured":"Quinn, J. A. et al. Phase II trial of temozolomide plus O6-benzylguanine in adults with recurrent, temozolomide-resistant malignant glioma. J Clin. Oncol. 27, 1262\u20131267. https:\/\/doi.org\/10.1200\/JCO.2008.18.8417 (2009).","DOI":"10.1200\/JCO.2008.18.8417"},{"key":"22674_CR48","doi-asserted-by":"publisher","first-page":"2565","DOI":"10.3390\/ijms22052565","volume":"22","author":"R Nakamura","year":"2021","unstructured":"Nakamura, R. et al. A simple method for in-depth proteome analysis of mammalian cell culture conditioned media containing fetal bovine serum. Int. J. Mol. Sci. 22, 2565. https:\/\/doi.org\/10.3390\/ijms22052565 (2021).","journal-title":"Int. J. Mol. Sci."},{"key":"22674_CR49","doi-asserted-by":"publisher","first-page":"757","DOI":"10.15252\/msb.20145625","volume":"10","author":"CS Hughes","year":"2014","unstructured":"Hughes, C. S. et al. Ultrasensitive proteome analysis using paramagnetic bead technology. Mol. Syst. Biol. 10, 757. https:\/\/doi.org\/10.15252\/msb.20145625 (2014).","journal-title":"Mol. Syst. Biol."},{"key":"22674_CR50","doi-asserted-by":"publisher","first-page":"4154","DOI":"10.1038\/s41467-023-39869-5","volume":"14","author":"F Yu","year":"2023","unstructured":"Yu, F. et al. Analysis of DIA proteomics data using MSFragger-DIA and FragPipe computational platform. Nat. Commun. 14, 4154. https:\/\/doi.org\/10.1038\/s41467-023-39869-5 (2023).","journal-title":"Nat. Commun."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-22674-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-22674-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-22674-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T13:29:37Z","timestamp":1762435777000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-22674-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,6]]},"references-count":50,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["22674"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-22674-z","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-5991999\/v1","asserted-by":"object"}]},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,6]]},"assertion":[{"value":"9 February 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 September 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"for all study protocols has been obtained from the Human Ethics Committee of the General University Hospital of Albacete, Spain (Ethical approval number: 03\/2014). This study adheres to the Declaration of Helsinki ethical principles for medical research involving human subjects, including its amendments.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}],"article-number":"38875"}}